Immediate-release tofacitinib reduces insulin resistance in non-diabetic active rheumatoid arthritis patients: A single-center retrospective study

BACKGROUND: An increased risk of insulin resistance (IR) has been identified in rheumatoid arthritis (RA), a chronic inflammatory disorder with elevated levels of pathogenic cytokines. Biologics targeting proinflammatory cytokines can control the disease and improve insulin sensitivity in RA. Althou...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chrong-Reen, Tsai, Hung-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210542/
https://www.ncbi.nlm.nih.gov/pubmed/35800413
http://dx.doi.org/10.4239/wjd.v13.i6.454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210542/
https://www.ncbi.nlm.nih.gov/pubmed/35800413
http://dx.doi.org/10.4239/wjd.v13.i6.454

Ejemplares similares